Mala Murthy - 03 Mar 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Mar 2023, 15:12:45 UTC
Prior SEC filing
03 Mar 2023
Next SEC filing
15 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Mala Murthy filed Form 4 for Teladoc Health, Inc. (TDOC) on 07 Mar 2023.

Key facts

  • This page summarizes Mala Murthy's Form 4 filing for Teladoc Health, Inc. (TDOC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 07 Mar 2023, 15:12.

Change

  • Previous filing in this sequence was filed on 03 Mar 2023.
  • Current net transaction value: -$192,726.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Sale

Transaction value
$192,726
Shares
-7,438
Change %
-16%
Price
$25.91
Shares after
39,414
Date
03 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+93,006
Change %
Price
$0.000000
Shares after
93,006
Date
03 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
93,006
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

Footnote F3

One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .